The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
NCT01092663
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Colesevelam HCl
DRUG:
Sitagliptin
Sponsor
KineMed